Kendall Park, NJ, United States of America

David Rosen

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 12.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Innovations by David Rosen: A Leader in Heterocycle Amines

Introduction

David Rosen, a prolific inventor based in Kendall Park, NJ, has made significant contributions to the fields of chemistry and medicine. With a remarkable portfolio of nine patents, Rosen has focused on advancing the science behind heterocycle amines and their applications in treating inflammatory disorders.

Latest Patents

Rosen's latest patents revolve around "Heterocycle Amines and Uses Thereof." The patents detail various compounds, compositions, and methods that harness the potential of heterocycle amines. These innovations aim to provide new therapeutic options for managing and treating inflammatory disorders, showcasing Rosen's commitment to medical advancement.

Career Highlights

Throughout his career, David Rosen has worked with reputable companies in the pharmaceutical industry, including Ligand Pharmaceuticals, Inc. and FMC Corporation. His experience in these organizations has enriched his expertise in the application of chemistry to solve complex medical challenges.

Collaborations

Rosen’s collaborative spirit is evident through his work alongside esteemed colleagues such as Koc-Kan Ho and David J. Diller. These collaborations have fostered an environment of innovation, enabling the development of groundbreaking solutions in the realm of medicinal chemistry.

Conclusion

In conclusion, David Rosen's contributions to the fields of chemistry and medicine through his innovative patents reflect his dedication to improving healthcare. His ongoing research and collaboration with industry leaders position him as a significant figure in the pursuit of new treatments for inflammatory disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…